News
Servier Appoints MaSTherCell for the Development of its CAR-T Cell Therapy Manufacturing Platform
Bioprocess InsiderServier Appoints MaSTherCell for the Development of its CAR-T Cell Therapy Manufacturing PlatformServier Appoints MaSTherCell for the Development of its CAR-T Cell Therapy Manufacturing Platform
MaSTherCell is developing a CAR-T cell therapy manufacturing platform, enabling industrial and commercial manufacturing of Servier cell therapy products.
Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.